CME Group (CME Group) ROCE % : 11.30% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CME Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CME Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 11.30%.

CME Group ROCE % Historical Data

The historical data trend for CME Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CME Group ROCE % Chart

CME Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

7.87

7.90

9.72

10.03

11.85

CME Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															13.03	11.36	10.80	11.30	12.77

CME Group ROCE % Calculation

CME Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	4313	/	( ( (174175.7 - 137687.5)	+	(129706.1 - 93416.9) )	/ 2 )
	=	4313	/	( (36488.2	+	36289.2)	/ 2 )
	=	4313	/	36388.7
	=	11.85 %

CME Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	4182.8	/	( ( (125598.2 - 87880.5)	+	(129706.1 - 93416.9) )	/ 2 )
	=	4182.8	/	( ( 37717.7	+	36289.2 )	/ 2 )
	=	4182.8	/	37003.45
	=	11.30 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

CME Group (NAS:CME) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CME Group ROCE % Related Terms

Thank you for viewing the detailed overview of CME Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

CME Group (CME Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

CME:Mexico MX4A:Germany MX4A:Germany CHME34:Brazil

Address

20 South Wacker Drive, Chicago, IL, USA, 60606

Website

https://www.cmegroup.com

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

Executives

William R Shepard	director	20 S. WACKER DR, CHICAGO IL 60606
Bryan T Durkin	officer: MD & COO	20 S. WACKER DRIVE, CHICAGO IL 60606
Derek Sammann	officer: Managing Dir Financial Product	20 S. WACKER DRIVE, CHICAGO IL 60606
Dennis Suskind	director	ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Suzanne Sprague	officer: Sr MD Global Head of Clearing	20 SOUTH WACKER DRIVE, 18S, CHICAGO IL 60606
Timothy Francis Mccourt	officer: Sr MD Global Head Equity & FX	20 S WACKER DRIVE, CHICAGO IL 60606
Elizabeth A Cook	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman	director	20 S. WACKER DR, CHICAGO IL 60606
Terrence A Duffy	director	20 S. WACKER DR, CHICAGO IL 60606
Julie Holzrichter	officer: MD Operations	20 S. WACKER DRIVE, CHICAGO IL 60606
Timothy S. Bitsberger	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Julie Winkler	officer: Chief Commercial Officer	20 S. WACKER DR., CHICAGO IL 60606
Daniel R Glickman	director	20 S. WACKER DR, CHICAGO IL 60606
Hilda Harris Piell	officer: MD, Organizational Development	20 S. WACKER DRIVE, CHICAGO IL 60606
Sunil Cutinho	officer: President, CME Clearing	20 S. WACKER DR., CHICAGO IL 60606